Peptides & Peptide Synthesis Products
Fmoc-N-Me-Leu-OH

Fmoc-N-Me-Leu-OH

Fmoc-N-Me-D-Leu-OH

Catalog No: 45202
(2R)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-4-methylpentanoic acid, CAS: 103478-63-3, MW: 367.44, Formula: C22H25NO4
$26.00
SKU
45202

Fast shipping · Pay by card or purchase order · Bulk quantities available — contact us

Fmoc-N-Me-D-Leu-OH
Nα-Fmoc-Nα-methyl-D-leucine; (2R)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-4-methylpentanoic acid

D-Leucine with a methyl group on the backbone nitrogen. The isobutyl side chain needs no protecting group, so the derivative goes into a standard Fmoc/tBu cycle; what differs is the tertiary amide this residue forms and its inverted α-carbon. Methylating the backbone nitrogen makes the amide it forms a tertiary amide, which removes a hydrogen-bond donor and restricts the local backbone. N-methyl scanning uses that to find which backbone NH groups a bioactive conformation depends on, and a library of N-methylated cyclic alanine pentapeptides was built to describe how multiple N-methylation modulates the conformation of cyclic peptides.

Coupling can be difficult at this residue, especially between consecutive N-methyl residues, so monitor it and optimize the conditions — PyAOP or PyBOP/HOAt performed best in the reported N-methyl-rich system, which was built from L residues — and repeat an incomplete coupling.

Racemization during activation is worth watching, because here it would give back the L residue. In one solution-phase model system, couplings of a Z-Ala-MeLeu peptide in the presence of added salts such as triethylamine hydrochloride gave 2.8–39% racemization by a range of methods, with polar solvents making it worse and excess base not, and only a few activation methods gave stereochemically pure product. Those are results on that model, not measurements on this derivative; check the stereochemistry where it matters.

Applications

  • N-methyl scans to map the backbone NH groups a bioactive sequence needs
  • Cyclic and conformationally constrained peptides containing an N-methyl-D-residue
  • Analogues of naturally N-methylated peptides
  • N-methylated hydrophobic positions in cyclic peptide series

Storage
Store refrigerated (2–8 °C) in a tightly closed container, and let it reach room temperature before opening.

References

  1. Chatterjee J et al. N-Methylation of Peptides: A New Perspective in Medicinal Chemistry. Accounts of Chemical Research 2008, 41, 1331–1342. doi:10.1021/ar8000603
  2. Teixidó M et al. Solid-phase synthesis and characterization of N-methyl-rich peptides. The Journal of Peptide Research 2005, 65, 153–166. doi:10.1111/j.1399-3011.2004.00213.x
  3. McDermott JR et al. N-Methylamino Acids in Peptide Synthesis. IV. Racemization and Yields in Peptide-bond Formation. Canadian Journal of Chemistry 1973, 51, 2562–2570. doi:10.1139/v73-386

For research use only. Not for human or veterinary use.

More Information
Catalog Number 45202
CAS 103478-63-3
M.W. 367.44
Formula C22H25NO4
IUPAC Name (2R)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-4-methylpentanoic acid
Also Known As
  • Fmoc-D-MeLeu-OH
  • Fmoc-D-N-Me-Leu-OH
  • Fmoc-N-methyl-D-leucine
  • N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-D-leucine
  • (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-methylpentanoic acid
InChIKey BUJQSIPFDWLNDC-HXUWFJFHSA-N
InChI InChI=1S/C22H25NO4/c1-14(2)12-20(21(24)25)23(3)22(26)27-13-19-17-10-6-4-8-15(17)16-9-5-7-11-18(16)19/h4-11,14,19-20H,12-13H2,1-3H3,(H,24,25)/t20-/m1/s1
SMILES CC(C)C[C@H](C(=O)O)N(C)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

The current Safety Data Sheet for Fmoc-N-Me-D-Leu-OH (Catalog No: 45202).

Download PDF

The Certificate of Analysis for each lot of Fmoc-N-Me-D-Leu-OH (Catalog No: 45202). Enter the lot number printed on the product label.

Write Your Own Review
You're reviewing:Fmoc-N-Me-D-Leu-OH